Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection

A mouse model of spontaneous latent tuberculosis infection (LTBI)that mimics latent tuberculosis infection in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial...

Full description

Bibliographic Details
Main Authors: Chuan eQin, Zhan eLingjun, tang ejun, lin eshuzhu, xu eyanfeng, xu eyuhuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01490/full
_version_ 1818439781394153472
author Chuan eQin
Zhan eLingjun
tang ejun
lin eshuzhu
xu eyanfeng
xu eyuhuan
author_facet Chuan eQin
Zhan eLingjun
tang ejun
lin eshuzhu
xu eyanfeng
xu eyuhuan
author_sort Chuan eQin
collection DOAJ
description A mouse model of spontaneous latent tuberculosis infection (LTBI)that mimics latent tuberculosis infection in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial load is difficult to establish. In this study, mice were IV-inoculated with 100 CFU Mycobacterium tuberculosis H37Rv, and a persistent LTBI was established with low bacterial loads (0.5~1.5log10 CFU in the lung; <4log10 CFU in the spleen). Histopathological changes in the lung, spleen, and liver were mild during the first 20 weeks post-inoculation. The model was used to demonstrate the comparative effects of prophylactic and therapeutic administration of Ganoderma lucidum extract (spores and spores lipid) in preventing H37Rv replication in both lung and spleen. H37Rv was inhibited with prophylactic use of G. lucidum extract relative to that of the untreated control and therapy groups, and observed in the spleen as early as post-inoculation week 3. H37Rv infection in the therapy group was comparable to that of the untreated control mice. No significant mitigation of pathological changes was observed in either the prophylactic or therapeutic groups. Our results suggest that this LTBI model is an efficient means of testing anti-tuberculosis vaccines and drugs. The use of G. lucidum extract prior to M. tuberculosis infection may protect the host against bacterial replication to some extent.
first_indexed 2024-12-14T18:01:55Z
format Article
id doaj.art-60b3e316417d4717b017d47d8406120a
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-14T18:01:55Z
publishDate 2016-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-60b3e316417d4717b017d47d8406120a2022-12-21T22:52:27ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2016-01-01610.3389/fmicb.2015.01490151788Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infectionChuan eQin0Zhan eLingjun1tang ejun2lin eshuzhu3xu eyanfeng4xu eyuhuan5Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)Insitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS)A mouse model of spontaneous latent tuberculosis infection (LTBI)that mimics latent tuberculosis infection in humans is valuable for drug/vaccine development and the study of tuberculosis. However, most LTBI mouse models require interventions, and a spontaneous LTBI mouse model with a low bacterial load is difficult to establish. In this study, mice were IV-inoculated with 100 CFU Mycobacterium tuberculosis H37Rv, and a persistent LTBI was established with low bacterial loads (0.5~1.5log10 CFU in the lung; <4log10 CFU in the spleen). Histopathological changes in the lung, spleen, and liver were mild during the first 20 weeks post-inoculation. The model was used to demonstrate the comparative effects of prophylactic and therapeutic administration of Ganoderma lucidum extract (spores and spores lipid) in preventing H37Rv replication in both lung and spleen. H37Rv was inhibited with prophylactic use of G. lucidum extract relative to that of the untreated control and therapy groups, and observed in the spleen as early as post-inoculation week 3. H37Rv infection in the therapy group was comparable to that of the untreated control mice. No significant mitigation of pathological changes was observed in either the prophylactic or therapeutic groups. Our results suggest that this LTBI model is an efficient means of testing anti-tuberculosis vaccines and drugs. The use of G. lucidum extract prior to M. tuberculosis infection may protect the host against bacterial replication to some extent.http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01490/fullmouse modelGanoderma lucidum extractspontaneous latent tuberculosis infectioninhibited Mycobacterium tuberculosis replicationProphylactic use
spellingShingle Chuan eQin
Zhan eLingjun
tang ejun
lin eshuzhu
xu eyanfeng
xu eyuhuan
Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
Frontiers in Microbiology
mouse model
Ganoderma lucidum extract
spontaneous latent tuberculosis infection
inhibited Mycobacterium tuberculosis replication
Prophylactic use
title Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
title_full Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
title_fullStr Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
title_full_unstemmed Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
title_short Prophylactic use of Ganoderma lucidum extract may inhibit Mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
title_sort prophylactic use of ganoderma lucidum extract may inhibit mycobacterium tuberculosis replication in a new mouse model of spontaneous latent tuberculosis infection
topic mouse model
Ganoderma lucidum extract
spontaneous latent tuberculosis infection
inhibited Mycobacterium tuberculosis replication
Prophylactic use
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01490/full
work_keys_str_mv AT chuaneqin prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection
AT zhanelingjun prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection
AT tangejun prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection
AT lineshuzhu prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection
AT xueyanfeng prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection
AT xueyuhuan prophylacticuseofganodermalucidumextractmayinhibitmycobacteriumtuberculosisreplicationinanewmousemodelofspontaneouslatenttuberculosisinfection